VCI Global Secures US$100 Million in Funding Commitment to Fuel Further Growth in the AI and Renewable Energy Sector
Notified -
Globe Newswire21-01-2025, 20:33
Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint 12-06-2024, 09:06
